Recordati Rare Diseases Revenue and Competitors
Estimated Revenue & Valuation
- Recordati Rare Diseases's estimated annual revenue is currently $76.4M per year.
- Recordati Rare Diseases's estimated revenue per employee is $201,000
Employee Data
- Recordati Rare Diseases has 380 Employees.
- Recordati Rare Diseases grew their employee count by 34% last year.
Recordati Rare Diseases's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Finance Global Rare Diseases (CFO) | Reveal Email/Phone |
2 | Head NA Commercial Operations | Reveal Email/Phone |
3 | VP Commercial - US Oncology | Reveal Email/Phone |
4 | Head Medical Oncology - LAC Region | Reveal Email/Phone |
5 | VP and Director Orphan Drugs | Reveal Email/Phone |
6 | Head Regulatory Affairs - Global endocrinology | Reveal Email/Phone |
7 | Pharmacovigilance Compliance Officer | Reveal Email/Phone |
8 | QA Compliance Manager, Deputy FvP | Reveal Email/Phone |
9 | Head Business Operations LAC Region MEDO & ENDO | Reveal Email/Phone |
10 | Head Group Supply Chain - RRD | Reveal Email/Phone |
Recordati Rare Diseases Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Recordati Rare Diseases?
At Recordati Rare Diseases, we focus on the few - those affected by rare diseases. We believe that every single patient has the right to the best possible treatment. Patients with rare diseases are our top priority. They are at the core of our planning, our thinking and our actions.
keywords:N/A
N/A
Total Funding
380
Number of Employees
$76.4M
Revenue (est)
34%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Recordati Rare Diseases News
2022-04-20 - Nephropathic Cystinosis Treatment Market Size And Forecast ...
... Chiesi Farmaceutici SpA, Leadiant Biosciences Eloxx Pharmaceuticals, GlaxoSmithKline plc., Recordati Rare Diseases, AVROBIO, Inc.
2022-03-30 - Recordati Rare Diseases Announce Publication in the Journal ...
Recordati Rare Diseases Announce Publication in the Journal of Clinical Endocrinology & Metabolism of the Phase III LINC 4 Study Confirming the...
Other Companies in Puteaux
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 389 | 20% | N/A |
#2 | $41.3M | 421 | 48% | N/A |
#3 | $131.8M | 517 | 22% | N/A |
#4 | $136.5M | 520 | 7% | N/A |
#5 | N/A | 596 | 7% | N/A |